Oxygen Concentrator Sales - Yahoo Search Results

- Inogen Inc (INGN) Q4 2020 Earnings Call Transcript | The Motley Fool
  The Motley Fool· 7 days ago
  INGN earnings call for the period ending December 31, 2020.
- Few in Hawaii spared the far-reaching consequences of the coronavirus pandemic
  Honolulu Star-Advertiser· 2 days ago
  Coby Torda still walks his dogs and works out at the gym just as he did before he became one of...
- Inogen (INGN) Launches One G5 Portable Oxygen Concentrator
  Zacks via Yahoo Finance· 2 years ago
  Inogen, Inc. INGN recently announced the launch of its Inogen One G5 portable oxygen concentrator....
- Inogen Inc (INGN) Q2 2019 Earnings Call Transcript
  Motley Fool via Yahoo Finance· 2 years ago
  Despite successful early trials where we allocated more leads to top performing representatives when scaled across...
- Edited Transcript of IVC.N earnings conference call or presentation 6-Aug-20 12:30pm GMT
  Thomson Reuters StreetEvents via Yahoo Finance· 7 months ago
  The profitability grew as a result of stronger gross margin from favorable sales mix, cost savings from continuous improvement initiatives and reduced SG&A expense. I'm pleased ...
- Here's Why You Should Retain Inogen in Your Portfolio Now
  Zacks via Yahoo Finance· 9 months ago
  Inogen, Inc. INGN is gaining on its solid product portfolio expansion and strong momentum within...
- ResMed (RMD) Rides on Strong SaaS Growth & New Product Suite
  Zacks via Yahoo Finance· 2 years ago
  On Jul 8, 2019, we issued an updated research report on ResMed Inc. RMD. The stock carries a Zacks...
- This Stock Was Down 30% -- Here's Why I Bought (a Lot) More
  Motley Fool via Yahoo Finance· 2 years ago
  Over the past few years, Chart Industries (NASDAQ: GTLS) has rewarded investors quite well. The...
- Here's Why You Should Invest in ResMed (RMD) Stock Right Now
  Zacks via Yahoo Finance· 1 year ago
  ResMed Inc. RMD has been gaining from several sales-building efforts — including product launches...
- 3 Top Healthcare Stocks to Buy in July
  Motley Fool via Yahoo Finance· 2 years ago
  We asked a team of Motley Fool contributors to weigh in, and they picked AbbVie (NYSE: ABBV), Intercept Pharmaceuticals (NASDAQ: ICPT), and Inogen...